JAPFA LTD.
UD2.SI
Japfa (JAP SP) - Feeding Asia’s Growing MiddleClass
An industrialised farmer beset by a down cycle
- Japfa is an agri-food company that has operations across five geographies (Indonesia, Vietnam, China, Myanmar and India) and animal proteins (poultry, pork, fish, beef and dairy). However, a weak operating environment across two of its main markets, Indonesia (poultry) and Vietnam (pork) has weighed heavily on its recent performance.
- Core net profit dived 65%/94% YoY in 1Q/2Q17 as operating margins contracted to 5%/7% due to falling average selling prices.
Macro-tailwinds boost top line
- Despite the weak bottom line, 1Q/2Q17 revenue edged 3%/1% higher on structural growth across key markets as Asia’s middle class gradually consume more animal protein in line with economic growth.
- Japfa prides itself as being an integrated industrialised farmer with emphasis on feed production across its key animal protein segments.
Smoothening out the cycles
- While Japfa is a price-taker in a manifestly cyclical space, it is looking at three main traits/initiatives to smoothen out these cycles. These include:
- a diversified animal protein portfolio across five geographies,
- a stable feed component of the animal protein business together with tight cost management to keep breakeven points low and benefit from any ASP uptick and
- moving downstream towards consumer end-products, which can potentially allow it to set prices of its own products.
Valuations appear cheap against less diversified peers
- Japfa currently trades at 8.9x forward P/E with two (1 Buy and 1 Sell) street ratings and an average TP of $0.72.
- This compares against 33.1x P/E of other vertically integrated industrialised farmers, 19.0x P/E of animal feed and 23.7x P/E of pure dairy peers.
Company Profile
Business
- Japfa is an industrial agri-food company based in Singapore, with a network of industrialised farms, processing and distribution facilities in Indonesia, China, Vietnam, India and Myanmar.
- Its animal protein segment is geographically spilt into Indonesia (51%-owned PT Japfa) and Others (Vietnam, Myanmar and India), which produces animal feed and animal proteins such as poultry, beef, pork and fish.
- Dairy operations are mainly carried out in China (upstream dairy farming) and Indonesia (vertically integrated dairy business).
- Japfa uses some of its animal protein products as raw materials for its consumer processed food segment, mainly for the Indonesian market.
Company milestones
- Commenced operations in 1975 with its first poultry feed mill in Surabaya, Indonesia.
- Japfa’s 51% owned Indonesia unit, PT Japfa Comfeed listed on the Jakarta Stock Exchange in 1989.
- Established dairy operations at a 6,000 head farm in Malang, East Java, Indonesia in 1997.
- Launched its “Greenfields” milk brand and processed consumer food brands in Indonesia in 2000.
- Set up its first “5-farms dairy hub” in Shandong, China in 2009. Diversified into swine operations in Vietnam in 2012, poultry operations in Myanmar in 2014.
- Listed on the Singapore Stock Exchange in 2014.
- FY16 sales from its four main operating segments comprise PT Japfa (67%), Animal Protein Other (19%), Dairy (9%), and Consumer Food (7%).
Investment Pros and Cons
Growth proposition
- Beneficiary of strong macro tailwind, which would see higher consumption of meat protein as economies grow.
- Well-diversified across animal proteins with strong exposure to key entry-level proteins such as chicken and pork. Also exposed to more expensive protein such as beef and fish.
- Its expertise in managing mega-scale farms such as the “5-farms hub” can be used to scale up operations across its main geographical markets.
- Able to replicate its best practices and infrastructure design across five protein groups and five countries. These include the farm design model in dairy farms, DOC breeding farms, feedmills etc.
- Nascent downstream operations where its dairy brand, “Greenfields” is doing particularly well in Indonesia (market leading position) as well as China.
Value proposition
- Currently in market leading positions across its key geographical markets, Indonesia (No. 2 in poultry-feed and DOC production), Vietnam (No. 2 in swine and DOC production), Myanmar (No. 2 in poultry-feed and DOC production) and China (No. 1 in milk yields).
- Possess industrialised farming expertise in the form of:
- Strict biosecurity SOPs including in-house vaccine production firm, PT Vaksindo.
- Technology and genetics know-how through its JVs with US-based poultry breeder, Aviagen and Dutch swine breeder, Hypor.
- Management of large scale animal feed business (FY16: 34 feed mills).
- Although trading at a cheaper 8.9x forward P/E and 1.2x P/B vs peers ~36x and ~3.6x P/B, Japfa’s forward ROE of 11% is weaker than its peers’ 16%.
Key risk factors
- Cyclicality risk – Japfa is exposed to cyclicality of the agri-food industry, but the diversified nature of its animal protein business helps improve resilience of sales relative to the operating environment of a single market. Nonetheless, a substantial decline in one or more large market such as Indonesia and/or Vietnam can have severe ramifications on group financials as seen in 1Q/2Q17.
- Regulatory risk – Japfa is also exposed to regulatory risk from government policies. Recently, the Chinese import ban on Vietnamese swine triggered an ASP slump which ultimately caused its 2Q17 bottom line plummet.
- Operational risk – Possible breakout of contagious livestock disease such as swine flu, bird flu and mad cow disease could result in substantial operational losses as well as impairments on its biological assets.
- Foreign currency risk – As Japfa reports in USD, FX adjustments will impact overall earnings when regional currencies depreciate/appreciate.
NOT RATED
Target Price: N/A
Simeon Ang
Maybank Kim Eng
|
http://www.maybank-ke.com.sg/
2017-08-29
Maybank Kim Eng
SGX Stock
Analyst Report
99998
Same
99998